栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/07/20 | 1,620 | 1,643 | 1,610 | 1,640 | +22 | +1.4% | 146,300 |
2020/07/17 | 1,638 | 1,645 | 1,617 | 1,618 | -18 | -1.1% | 110,400 |
2020/07/16 | 1,647 | 1,662 | 1,635 | 1,636 | -16 | -1% | 180,100 |
2020/07/15 | 1,661 | 1,666 | 1,628 | 1,652 | +5 | +0.3% | 210,600 |
2020/07/14 | 1,667 | 1,679 | 1,635 | 1,647 | -15 | -0.9% | 302,500 |
2020/07/13 | 1,610 | 1,673 | 1,610 | 1,662 | +68 | +4.3% | 448,900 |
2020/07/10 | 1,574 | 1,602 | 1,562 | 1,594 | +16 | +1% | 350,500 |
2020/07/09 | 1,614 | 1,619 | 1,575 | 1,578 | -40 | -2.5% | 318,900 |
2020/07/08 | 1,613 | 1,645 | 1,607 | 1,618 | -13 | -0.8% | 333,800 |
2020/07/07 | 1,640 | 1,642 | 1,600 | 1,631 | -19 | -1.2% | 441,900 |
2020/07/06 | 1,672 | 1,672 | 1,640 | 1,650 | -4 | -0.2% | 239,700 |
2020/07/03 | 1,657 | 1,658 | 1,631 | 1,654 | +13 | +0.8% | 310,400 |
2020/07/02 | 1,682 | 1,684 | 1,630 | 1,641 | -42 | -2.5% | 477,300 |
2020/07/01 | 1,730 | 1,736 | 1,675 | 1,683 | -41 | -2.4% | 513,400 |
2020/06/30 | 1,725 | 1,739 | 1,704 | 1,724 | +8 | +0.5% | 405,000 |
2020/06/29 | 1,729 | 1,745 | 1,703 | 1,716 | -4 | -0.2% | 386,600 |
2020/06/26 | 1,739 | 1,739 | 1,707 | 1,720 | +1 | +0.1% | 264,400 |
2020/06/25 | 1,738 | 1,760 | 1,713 | 1,719 | -47 | -2.7% | 379,500 |
2020/06/24 | 1,800 | 1,808 | 1,746 | 1,766 | -32 | -1.8% | 411,100 |
2020/06/23 | 1,818 | 1,837 | 1,777 | 1,798 | -10 | -0.6% | 406,500 |
2020/06/22 | 1,796 | 1,815 | 1,777 | 1,808 | +31 | +1.7% | 308,300 |
2020/06/19 | 1,805 | 1,813 | 1,758 | 1,777 | -18 | -1% | 715,300 |
2020/06/18 | 1,800 | 1,806 | 1,778 | 1,795 | +2 | +0.1% | 264,400 |
2020/06/17 | 1,800 | 1,810 | 1,776 | 1,793 | -1 | -0.1% | 278,400 |
2020/06/16 | 1,772 | 1,794 | 1,754 | 1,794 | +52 | +3% | 389,900 |
2020/06/15 | 1,780 | 1,838 | 1,742 | 1,742 | -31 | -1.7% | 502,300 |
2020/06/12 | 1,722 | 1,781 | 1,717 | 1,773 | +1 | +0.1% | 519,900 |
2020/06/11 | 1,818 | 1,822 | 1,771 | 1,772 | -77 | -4.2% | 419,100 |
2020/06/10 | 1,840 | 1,852 | 1,821 | 1,849 | -1 | -0.1% | 319,500 |
2020/06/09 | 1,841 | 1,871 | 1,832 | 1,850 | +1 | +0.1% | 414,500 |
2020/06/08 | 1,910 | 1,910 | 1,839 | 1,849 | -50 | -2.6% | 517,100 |
2020/06/05 | 1,930 | 1,930 | 1,888 | 1,899 | -42 | -2.2% | 746,600 |
2020/06/04 | 1,995 | 2,015 | 1,911 | 1,941 | -35 | -1.8% | 1,020,300 |
2020/06/03 | 1,896 | 1,989 | 1,870 | 1,976 | +86 | +4.6% | 2,283,800 |
2020/06/02 | 1,880 | 1,894 | 1,865 | 1,890 | -13 | -0.7% | 438,700 |
2020/06/01 | 1,894 | 1,927 | 1,891 | 1,903 | +58 | +3.1% | 680,000 |
2020/05/29 | 1,811 | 1,846 | 1,794 | 1,845 | +30 | +1.7% | 543,300 |
2020/05/28 | 1,830 | 1,848 | 1,798 | 1,815 | +20 | +1.1% | 652,100 |
2020/05/27 | 1,725 | 1,795 | 1,724 | 1,795 | +59 | +3.4% | 499,700 |
2020/05/26 | 1,732 | 1,743 | 1,725 | 1,736 | +15 | +0.9% | 296,600 |
2020/05/25 | 1,714 | 1,734 | 1,701 | 1,721 | +26 | +1.5% | 272,900 |
2020/05/22 | 1,692 | 1,703 | 1,680 | 1,695 | -10 | -0.6% | 444,400 |
2020/05/21 | 1,705 | 1,724 | 1,697 | 1,705 | -3 | -0.2% | 273,500 |
2020/05/20 | 1,709 | 1,718 | 1,692 | 1,708 | -19 | -1.1% | 319,300 |
2020/05/19 | 1,735 | 1,755 | 1,711 | 1,727 | +7 | +0.4% | 284,700 |
2020/05/18 | 1,727 | 1,742 | 1,703 | 1,720 | -27 | -1.5% | 329,900 |
2020/05/15 | 1,759 | 1,773 | 1,711 | 1,747 | +9 | +0.5% | 411,200 |
2020/05/14 | 1,792 | 1,808 | 1,738 | 1,738 | -81 | -4.5% | 695,900 |
2020/05/13 | 1,861 | 1,863 | 1,795 | 1,819 | -46 | -2.5% | 590,700 |
2020/05/12 | 1,819 | 1,874 | 1,792 | 1,865 | +25 | +1.4% | 539,800 |
1051~
1100
件表示中 / 6826件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 232,200円 | +0.4% | -8.4% | 2.28% | 30.69倍 | 1.75倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 121,300円 | +197.7% | - | 0.00% | 49.57倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 67,900円 | -3.7% | -36.7% | 2.95% | 23.03倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 101,300円 | - | - | 0.00% | - | 51.01倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム